Ovarian cysts, clomiphene therapy, and the risk of neural tube defects

International Journal of Gynecology and Obstetrics

Volumn 100, Issue 1, 2008, Pages 86-88

  Banhidy F ^a   Acs N ^a   Czeizel, A E ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

Author keywords

Clomiphene citrate; Follicular cyst of the ovary; Neural tube defects

Indexed keywords

CLOMIFENE CITRATE;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENVIRONMENTAL EXPOSURE; FOLLICLE CYST; HUMAN; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; NEWBORN; OVARY CYST; OVARY HYPERSTIMULATION; PRENATAL CARE; PRIORITY JOURNAL; RISK FACTOR; SOCIAL STATUS;

EID: 36749026330     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2007.05.048     Document Type: Article

References (5)

1. Shepard T.H., and Lemire R.J. Catalog of teratogenic agents. 11th ed (2004), Johns Hopkins University Press, Baltimore MD, USA
2. Czeizel A.E., Rockenbauer M., Siffel C., and Varga E. Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996. Teratology 63 (2001) 176-185
3. Asch R.H., and Greenblatt R.B. Update on the safety and efficacy of clomiphene citrate as a therapeutic agent. J Reprod Med 17 (1976) 175-180
4. Nevin N.C., and Harley J.M. Clomiphene and neural tube defects. Ulster Med J 45 (1976) 59-64
5. Cuckle H., and Wald N. Ovulation induction and neural tube defects. Lancet 2 (1989) 1281